fda
13 records
FDA Drug Recall: Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bott
2026-03-25
Class II — Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
View Source
FDA Drug Recall: Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Ph
2025-08-06
Class II — Failed Dissolution Specifications.
View Source
FDA Drug Recall: Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distrib
2025-04-02
Class II — Presence of foreign substance: Presence of Benzene.
View Source
FDA Drug Recall: Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Dist
2025-04-02
Class II — Presence of foreign substance: Presence of Benzene.
View Source
FDA Drug Recall: Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strid
2024-01-31
Class II — Failed Dissolution Specifications
View Source
FDA Drug Recall: Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx
2023-07-12
Class II — Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
View Source
FDA Drug Recall: Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strid
2022-08-17
Class II — Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets
View Source
FDA Drug Recall: Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life S
2022-06-08
Class II — CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
View Source
FDA Drug Recall: Losartan Potassium Tablets, USP, 100 mg, Rx Only, Manufactured by: Vivimed Life
2022-06-08
Class II — CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
View Source
FDA Drug Recall: Losartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life S
2022-06-08
Class II — CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
View Source
FDA Drug Recall: Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, R
2021-10-20
Class II — Failed Dissolution Specifications
View Source
FDA Drug Recall: NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured
2021-01-06
Class III — Failed Moisture Limits
View Source
FDA Drug Recall: Benzonatate capsules, 200 mg, 100-count bottle, Rx only, Manufactured by: Stride
2017-05-31
Class III — Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.
View Source
fda_adverse
2 records
FDA AE Manufacturer: Strides Pharma Inc.
Drug adverse event reporter — Product: HYDROCORTISONE
View Source
FDA AE Manufacturer: Strides Pharma Inc
Drug adverse event reporter — Product: IBUPROFEN
View Source
ny_corps
1 records
NY Corp: STRIDES PHARMA, INC.
2021-09-29
FOREIGN BUSINESS CORPORATION | County: Rockland | Jurisdiction: New Jersey
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.